Related Experiment Video
Updated: Jul 9, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Fluoroquinolone resistance in Neisseria meningitidis in Spain
Rocío Enríquez1, Raquel Abad, Celia Salcedo
1Reference Laboratory for Meningococci, Servicio de Bacteriología, National Centre for Microbiology, National Institute of Health Carlos III, Majadahonda, Madrid, Spain.
Objectives:
To assess the ciprofloxacin resistance of Neisseria meningitidis isolated from 1999 through 2006 in Spain, susceptibility testing was conducted on 5300 isolates.
Methods:
Ten isolates showed MICs of ciprofloxacin ranging between 0.06 and 0.25 mg/L, and they were characterized by analysis for mutations within the quinolone resistance determining regions (QRDRs) in the gyrA, gyrB, parC and parE genes. Mutations in the mtrR gene were also analysed.
Results And Conclusions:
Single mutations in gyrA appeared to be the main mechanism involved, Thr-91-->Ile being the most frequent substitution seen. Two meningococci had four different gyrA substitutions. No mutations in the QRDRs of the parC and gyrB genes were detected, and three strains showed a His-495-->Asn substitution in the parE gene. In addition, two different alterations in the mtrR gene affecting the expression of the MtrCDE efflux system were identified which may also contribute to the reduced susceptibility to quinolones seen in three strains.
Insights
Ciprofloxacin resistance in Neisseria meningitidis is mainly due to gyrA mutations. Other genetic changes in gyrA, parE, and mtrR also contribute to reduced susceptibility in these meningococcal isolates.
Area of Science:
- Microbiology
- Genetics
- Pharmacology
Background:
- Neisseria meningitidis is a significant human pathogen.
- Quinolones, including ciprofloxacin, are used to treat bacterial infections.
- Understanding antimicrobial resistance mechanisms is crucial for effective treatment.
Purpose of the Study:
- To investigate ciprofloxacin resistance in Neisseria meningitidis.
- To identify genetic mutations associated with quinolone resistance.
Main Methods:
- Susceptibility testing of 5300 Neisseria meningitidis isolates.
- Analysis of mutations in quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC, and parE genes.
- Investigation of mutations in the mtrR gene and their effect on the MtrCDE efflux system.
Main Results:
- Ten isolates exhibited reduced susceptibility to ciprofloxacin (MICs 0.06–0.25 mg/L).
- Single mutations in the gyrA gene, particularly Thr-91-->Ile, were the primary mechanism of resistance.
- No mutations were found in the QRDRs of parC and gyrB.
- Three strains had a His-495-->Asn substitution in the parE gene.
- Two alterations in the mtrR gene were identified, potentially affecting the MtrCDE efflux system.
Conclusions:
- Single gyrA mutations are the predominant mechanism for ciprofloxacin resistance in Neisseria meningitidis.
- Mutations in parE and alterations in the mtrR gene may also contribute to reduced quinolone susceptibility.
- These findings highlight the genetic basis of meningococcal resistance to fluoroquinolones.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Bacterial Meningitis